AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)
Taiwan · Delayed Price · Currency is TWD 60.70
-2.60 (-4.11%)
Sep 8, 2026, 1:58 PM CST
AnnJi Pharmaceutical Revenue
AnnJi Pharmaceutical had revenue of 540.00K TWD in the half year ending June 30, 2026, a decrease of -99.32%. This brings the company's revenue in the last twelve months to 959.00K, down -95.98% year-over-year. In the year 2025, AnnJi Pharmaceutical had annual revenue of 7.55M, down -92.17%.
Revenue (ttm)
959.00K
Revenue Growth
-95.98%
P/S Ratio
6,662.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.39B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.55M | -88.90M | -92.17% |
| Dec 31, 2024 | 96.45M | -47.08M | -32.80% |
| Dec 31, 2023 | 143.53M | 141.90M | 8,727.18% |
| Dec 31, 2022 | 1.63M | 191.00K | 13.31% |
| Dec 31, 2021 | 1.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.45B |
| Adimmune | 1.37B |
| Medigen Biotechnology | 1.27B |
| Savior Lifetec | 1.12B |
| PharmaEngine | 1.03B |
| Mycenax Biotech | 815.87M |
| Tanvex BioPharma | 657.56M |
| TaiGen Biopharmaceuticals Holdings | 256.46M |